logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Smit, Alwyn Jacobus Nicolaas
    Born in January 1961
    Individual (10 offsprings)
    Officer
    icon of calendar 2021-02-05 ~ now
    OF - Director → CIF 0
  • 2
    Nichol, Karen Yvonne
    Born in June 1967
    Individual (6 offsprings)
    Officer
    icon of calendar 2021-02-05 ~ now
    OF - Director → CIF 0
  • 3
    De Beer, Schalk Willem
    Born in November 1961
    Individual (1 offspring)
    Officer
    icon of calendar 2022-03-28 ~ now
    OF - Director → CIF 0
  • 4
    icon of addressCentral Pharma, Caxton Road, Elm Farm Ind Estate, Bedford, United Kingdom
    Active Corporate (4 parents, 4 offsprings)
    Profit/Loss (Company account)
    -108,199 GBP2024-01-01 ~ 2024-12-31
    Person with significant control
    icon of calendar 2021-02-05 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
parent relation
Company in focus

CENTRAL PHARMA BIOTECHNICA LIMITED

Standard Industrial Classification
96090 - Other Service Activities N.e.c.
Brief company account
Turnover/Revenue
562,944 GBP2024-01-01 ~ 2024-12-31
538,600 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
-453,700 GBP2024-01-01 ~ 2024-12-31
-326,771 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
109,244 GBP2024-01-01 ~ 2024-12-31
211,829 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-416,558 GBP2024-01-01 ~ 2024-12-31
-483,135 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
-307,314 GBP2024-01-01 ~ 2024-12-31
-271,306 GBP2023-01-01 ~ 2023-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
9,610 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-307,314 GBP2024-01-01 ~ 2024-12-31
-261,696 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
5 GBP2024-12-31
5 GBP2023-12-31
Property, Plant & Equipment
18,581 GBP2024-12-31
23,313 GBP2023-12-31
Fixed Assets
18,586 GBP2024-12-31
23,318 GBP2023-12-31
Total Inventories
138,606 GBP2024-12-31
260,554 GBP2023-12-31
Debtors
72,731 GBP2024-12-31
106,275 GBP2023-12-31
Cash at bank and in hand
48,796 GBP2024-12-31
104,825 GBP2023-12-31
Current Assets
260,133 GBP2024-12-31
471,654 GBP2023-12-31
Net Current Assets/Liabilities
-1,328,280 GBP2024-12-31
-1,025,698 GBP2023-12-31
Total Assets Less Current Liabilities
-1,309,694 GBP2024-12-31
-1,002,380 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
1 GBP2022-12-31
Retained earnings (accumulated losses)
-1,309,695 GBP2024-12-31
-1,002,381 GBP2023-12-31
-740,685 GBP2022-12-31
Equity
-1,309,694 GBP2024-12-31
-1,002,380 GBP2023-12-31
-740,684 GBP2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-307,314 GBP2024-01-01 ~ 2024-12-31
-261,696 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
-307,314 GBP2024-01-01 ~ 2024-12-31
-261,696 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
32024-01-01 ~ 2024-12-31
72023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
4,732 GBP2024-01-01 ~ 2024-12-31
4,732 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Net goodwill
1 GBP2023-12-31
Other than goodwill
4 GBP2023-12-31
Intangible Assets - Gross Cost
5 GBP2023-12-31
Intangible Assets
Net goodwill
1 GBP2024-12-31
1 GBP2023-12-31
Other than goodwill
4 GBP2024-12-31
4 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
39,718 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
21,137 GBP2024-12-31
16,405 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
4,732 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Plant and equipment
18,581 GBP2024-12-31
23,313 GBP2023-12-31
Trade Debtors/Trade Receivables
Amounts falling due within one year, Current
18,533 GBP2024-12-31
Current, Amounts falling due within one year
79,888 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
40,716 GBP2024-12-31
Other Debtors
Amounts falling due within one year, Current
13,482 GBP2024-12-31
Current, Amounts falling due within one year
26,387 GBP2023-12-31
Debtors
Amounts falling due within one year, Current
72,731 GBP2024-12-31
Current, Amounts falling due within one year
106,275 GBP2023-12-31
Trade Creditors/Trade Payables
Current
25,243 GBP2024-12-31
62,280 GBP2023-12-31
Amounts owed to group undertakings
Current
1,393,393 GBP2024-12-31
1,138,243 GBP2023-12-31
Other Taxation & Social Security Payable
Current
12,045 GBP2024-12-31
77,101 GBP2023-12-31
Other Creditors
Current
157,732 GBP2024-12-31
219,728 GBP2023-12-31
  • CENTRAL PHARMA BIOTECHNICA LIMITED
    Info
    Registered number 13182798
    icon of addressCentral Pharma Caxton Road, Elm Farm Ind Estate, Bedford MK41 0HT
    PRIVATE LIMITED COMPANY incorporated on 2021-02-05 (4 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-04
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.